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Age-related defects in stem cells can limit proper tissue maintenance and hence contribute to a shortened lifespan.
Using highly purified hematopoietic stem cells from mice aged 2 to 21 mo, we demonstrate a deficit in function yet an
increase in stem cell number with advancing age. Expression analysis of more than 14,000 genes identified 1,500 that
were age-induced and 1,600 that were age-repressed. Genes associated with the stress response, inflammation, and
protein aggregation dominated the up-regulated expression profile, while the down-regulated profile was marked by
genes involved in the preservation of genomic integrity and chromatin remodeling. Many chromosomal regions
showed coordinate loss of transcriptional regulation; an overall increase in transcriptional activity with age and
inappropriate expression of genes normally regulated by epigenetic mechanisms was also observed. Hematopoietic
stem cells from early-aging mice expressing a mutant p53 allele reveal that aging of stem cells can be uncoupled from
aging at an organismal level. These studies show that hematopoietic stem cells are not protected from aging. Instead,
loss of epigenetic regulation at the chromatin level may drive both functional attenuation of cells, as well as other
manifestations of aging, including the increased propensity for neoplastic transformation.
Citation: Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, et al. (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS
Biol 5(8): e201. doi:10.1371/journal.pbio.0050201
Introduction
Somatic stem cells replenish many tissues throughout life.
In general, they have slow turnover and reside in specialized
niches, protected from the environment, so that only a few
are activated at a time. Thus, stem cells are a defense against
aging, replacing cells lost through attrition. If the rejuvenat-
ing effect of stem cells were perfect, senescing cells would be
replaced indeﬁnitely; but even in highly regenerative tissues
such as the skin, the gut, and the hematopoietic system, age-
related decline in function is well established [1]. Still unclear
are the effects of aging on the stem cells themselves, which
could contribute to inferior tissue repair.
Hematopoietic stem cells (HSCs) continuously replenish
the blood and immune system throughout life. Data from
mice support an age-related decline in stem cell function [1],
suggesting that older HSCs are inadequate to cope with the
demands of blood production. When limited numbers of aged
hematopoietic progenitors are transplanted into young
recipients under competitive conditions, they show an overall
reduction in long-term repopulating potential [2]; in partic-
ular, lymphopoiesis is deﬁcient, whereas myelopoiesis is
enhanced [3,4]. Paradoxically, however, the total number of
primitive progenitors has been reported to increase with age
in the C57Bl/6 mice [2,5]. A recent study of aged hema-
topoietic stem and progenitor cells suggested that increased
expression of particular proto-oncogenes may underlie some
of these observed changes [4].
Although the previous studies varied widely, the ﬁndings
provide compelling evidence for major age-related alter-
ations in HSC function. To gain insight into the molecular
mechanisms that underlie these deﬁcits, we examined gene
expression in HSC as a function of age on a genome-wide
scale in normal and an early-aging p53 mutant strain. These
data provide a comprehensive molecular portrait of aging in
HSC, and show that stem cell aging mirrors the aging of other
tissues, marked by a dramatic inﬂammatory response, stress
responses, and substantial alterations in the regulation of
chromatin structure.
Results
Phenotypically Defined HSCs Increase in Number with
Age and Possess a Functional Defect
The number of whole bone marrow (WBM) progenitors
deﬁned by cell surface markers in C57Bl/6 mice increases
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PLoS BIOLOGYwith age relative to total WBM cellularity [2,5]. To assess
whether this property extends to HSCs puriﬁed using the
side population (SP) cells deﬁned by their ability to efﬂux
Hoechst 33342 dye [6], we examined the SP cells in C57Bl/6
mice ranging from 2 to 21 mo of age. The results
demonstrate a 9-fold increase in the number of SP cells with
age (Figure 1A), with the most primitive SP
low cells [7]
showing the greatest increase. These SP cells also exhibit the
surface phenotype of HSC regardless of age (c-kit
pos,
lineage
neg, and Sca-1
pos [SParKLS]), consistent with their
high degree of purity and homogeneity (Figures 1B and S1).
Aged HSCs were uniformly CD48
neg, which is one of the
markers recently described to mark differentiated hemato-
poietic cells from both young and aged mice [8,9] (unpub-
lished data). Thus, murine HSCs deﬁned by multiple
phenotypes increase 9-fold in WBM over approximately 2 y.
The increase in cell number was not a result of greater
proportion of S-phase HSCs, as determined by propidium
iodide staining (Figure 1C), suggesting an alternative mech-
anism for the increase in HSC number.
Limiting dilution bone marrow transplantation can meas-
ure the ability of HSCs to reconstitute recipients under
competitive conditions and the functional purity of HSC [10].
HSCs (SParKLS) were therefore puriﬁed from either 2- or 21-
mo-old mice and transplanted into lethally irradiated
recipients, along with competitor bone marrow. Progeny
from donor HSC were distinguished from competitor and
recipient cells using the CD45 allelic system [11]. The
proportion of peripheral blood progeny derived from
puriﬁed young and old HSC was monitored at 4, 8, and 16
wk post-transplantation. Four weeks after transplantation,
there was little difference in the contribution of young versus
old HSCs (Figure 1D), but at 8 and 16 wk post-transplant, the
contribution from the old HSCs was signiﬁcantly reduced,
but still multilineage (Figure S2). This ﬁnding argues that
HSCs acquire a defect in long-term, but not short-term,
repopulating potential with increasing age. This deﬁcit
represents roughly a 3-fold loss in functional activity per
puriﬁed stem cell. With a 5- to 10-fold numerical increase in
HSC, this indicates that the total stem cell activity remains
fairly constant with age, which is consistent with other
reports [2,12].
Gene Expression Changes in Aging HSCs by Microarray
Analysis
To identify transcriptional changes in aged HSCs that
correlate with the observed functional deﬁcit, we examined
the expression of more than 14,000 genes, using Affymetrix
MOE430a microarrays and HSCs puriﬁed from 2-, 6-, 12-, and
21-mo-old mice. A quadratic trend line (parabola) was ﬁt for
each gene over the 19-mo test period, which showed that the
genes generally either increased or decreased in expression in
a time-dependent fashion. We used a linear contrast model
based on the entire observation course to determine which
genes had the largest changes in expression over time. This
revealed 1,600 genes that were up-regulated at 21 mo (‘‘Up-
with-Age’’ group), and 1,500 that were down-regulated
(‘‘Down-with-Age’’ group), which is summarized as a heat
map in Figure 2. A small hand-picked list is shown in Table 1;
the entire list of differentially expressed genes is supple-
mented in Tables S1 and S2, and a searchable database of all
genes on the array can be found at http://rd.plos.org/pbio.
0050201. Expression changes of a subset of these genes were
validated by real-time quantitative PCR in duplicate on
independently puriﬁed HSC (Figure S3). We also compared
transcriptional proﬁles for WBM versus HSCs to identify
HSC-speciﬁc transcripts; surprisingly, only a modest overlap
of genes was found with those that were up-regulated or
down-regulated with age, suggesting that the HSC-speciﬁc
transcriptional programs remain relatively stable as the
organism ages (Figure 2). A remarkable overlap was found
between genes up- and down-regulated with age in this study
and a previous study of HSC aging, with the top ten genes
being identical [4].
Gene Ontology Categories Enriched for Age-Induced or
Age-Repressed Genes
We next sought to identify biological processes that were
enriched in age-induced or age-repressed genes, compared to
chance alone. For this purpose, we used Gene Ontology (GO;
http://www.geneontology.org) to group genes on the basis of a
particular biological process [13], and identiﬁed GO catego-
ries that were enriched with statistical signiﬁcance by a
method previously reported [14]. When applied to the Up-
with-Age gene list, the analysis revealed a large number of
enriched categories that have been linked to aging in general,
such as NO-mediated signal transduction, the stress response
(protein folding), and the inﬂammatory response, whereas
categories enriched for Down-with-Age genes often included
those involved in the preservation of genomic integrity, such
as chromatin remodeling and DNA repair (Figure 3A) (the
entire GO results can be found at http://rd.plos.org/pbio.
0050201).
NF-jB and P-Selectin Are Activated in Aged HSCs
A link between aging and inﬂammation has been demon-
strated in several vertebrate models and in humans [15], and
we found evidence for the age-dependent regulation of
several stress-related genes in HSCs. One of the most highly
up-regulated of these genes expresses P-selectin, a cell surface
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Author Summary
Aging is marked by a decline in function of the entire organism. The
effect of age on the regenerative capacity of adult stem cells, which
should rejuvenate tissues throughout life, is poorly understood.
Bone marrow stem cells, also known as hematopoietic stem cells
(HSCs), continuously regenerate the cells that comprise the blood,
including the immune system, which fails with age. Here, we show
that older HSCs were less able to regenerate the blood system than
young HSCs. Paradoxically, the HSC number increased concom-
itantly, leading to no major difference in overall blood production,
even though the immune system did exhibit some defects. To
determine why these changes occurred, we looked at global
patterns of gene expression in young versus old HSC. Stem cells
exhibited an elevated inflammatory response and a decline in
factors, called chromatin regulators, that orchestrate DNA accessi-
bility and gene expression. Additional evidence supports the idea
that loss of overall gene regulation (epigenetic regulation) is a major
event during aging. Whereas much of aging research is concen-
trated on accumulation of mutations in DNA rather than on global
regulatory mechanisms, we speculate that these epigenetic changes
could drive many of the manifestations of age. This view also may
explain the increased incidence of cancer with age.Figure 1. Aging HSC Phenotypes and Functional Alterations
(A) Hoechst dye efflux by HSCs results in a SP (boxed) when viewed at two emission wavelengths. Comparison of the proportions of Sca-1–enriched SP
cells from C57Bl/6 mice at 2 and 21 mo of age shows an approximate 9-fold increase with age.
(B) Expression of the two canonical stem cell markers, c-Kit and Sca-1, does not change significantly between 2 and 21 mo of age within the lineage-
negative (Lin
 ) SP population, indicating the SP cells remain remarkably phenotypically pure and homogeneous.
(C) Cell cycle analysis by propidium iodide staining of 2- and 23-mo-old HSCs purified on the basis of SParKLS.
(D) Limiting dilution functional assay of HSCs. In competitive repopulation experiments, there was little difference in HSC activity 4 wk after
transplantation in young versus old HSCs. However, at 8 and 16 wk post-transplantation, 21-mo-old HSCs showed a reduced contribution compared to
2-mo-old control HSCs, depending on the donor cell dose (a single asterisk [*] indicates p   0.03; double asterisks [**] indicate p   0.09). Error bars
represent one standard error.
doi:10.1371/journal.pbio.0050201.g001
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Epigenetic Dysregulation with Ageadhesion molecule that serves as a marker for physiological
stress states, including inﬂammation [16], aging [17], and
cardiovascular disease [18]. P-selectin expression in HSCs,
was of particular interest because it mediates the leukocyte–
vascular endothelium interaction important for leukocyte
extravasation [16] and therefore has implications for HSC
migration. Flow cytometric analysis demonstrated increasing
levels of P-selectin on the surface of HSCs isolated from 24-
to 28-mo-old mice (21%–81%, Figure 4A), in contrast to
scant levels (3%) on HSCs from young mice.
We hypothesized that the p65 isoform of NF-jB, which
transcriptionally regulates P-selectin [19] would be activated
in aged HSCs. To test this, we puriﬁed HSCs from 2- and 22-
mo-old mice, and examined them for p65 localization by
immunoﬂuorescence. In contrast to only 3% of 2-mo-old
HSCs, 71% of 22-mo-old HSCs showed enhanced nuclear
localization of p65 protein (Figure 4B and 4C). These results
implicate NF-jB activation as the mechanism of increased P-
selectin expression in aged HSCs, most likely reﬂecting a
time-dependent rise in inﬂammation.
Timing of Gene Induction/Repression in Aging HSCs
The time course of data allowed us to examine the timing
of changes in age-regulated gene expression. We determined
when the trend line for each given gene achieved half its
maximum change over the full time course (T
1/2-max), then
grouped the genes by GO category and plotted the results for
those categories that had a signiﬁcant enrichment in the
previous analysis (Figure 3A), creating a GO-timer. As shown
in Figure 3B, genes that participate in NO-mediated signal
transduction were the ﬁrst to be up-regulated during HSC
aging, followed closely by those contributing to the stress
response and the regulation of lymphocyte proliferation.
Inﬂammatory-response genes were not activated until late in
the aging process, after up-regulation of NF-jB signaling,
strengthening our hypothesis that inﬂammation exerts a
strong inﬂuence on HSC aging through stimulation of the
NF-jB pathway. Complete GO-timer results can be found at
http://rd.plos.org/pbio.0050201.
Centers-of-Regulated Expression Analysis
In Saccharomyces cerevisiae, the chromatin regulatory factor
Sir2, a NAD-dependent histone deacetylase, suppresses
recombination and silences transcription at multiple ge-
nomic loci [20]; its loss is associated genomic instability and
aging. Since genes involved in chromatin remodeling and
transcriptional silencing were excessively down-regulated in
our GO enrichment analysis, we predicted global dysregula-
tion of transcriptional activity. We reasoned that this would
be evidenced by ﬁnding regions of chromosomes in which
genes that were physically clustered together changed
coordinately with age. To test this idea, genes were ordered
by their chromosomal position, and age-induced and age-
repressed genes were mapped using a density-based statistical
approach. The result was a single curve across each
chromosome, with peaks representing regions of coordinate
up-regulation, and valleys regions of coordinate down-
regulation (Figure 5A). Chromosomal loci with signiﬁcant
coordinate changes in gene expression were identiﬁed as
centers of regulated expression (COREs; Figure 5A, red lines).
Using this method, we found more than 100 such COREs
among the 19 mouse autosomes (Table S3). Importantly, there
were twice as many CORE peaks as there were valleys,
indicating a predominance of a loss of transcriptional
silencing throughout the genome.
Two recent linkage analyses in BXD mice indicated 22
chromosomal regions, or quantitative trait loci (QTLs),
containing genes regulating hematopoietic progenitor num-
ber and organism lifespan [21,22]. We therefore asked
whether any of the 17 mapped QTL loci might correspond
to COREs. Eight of the QTLs mapped to seven COREs on
Chromosomes 2, 4, and 7 (Figure 5C), consistent with the
possibility that the QTL-associated genes on these chromo-
somes may play a critical role in regulating lifespan and HSC
number. When compared to other non–HSC-related QTL
datasets obtained from WebQTL [23], we observed a much
greater overlap with the Henckaerts, et al. dataset [22] (p-
value ¼ 0.06).
Immunoglobulin Kappa Expression Provides Evidence for
Chromatin Dysregulation
With such dramatic changes in chromatin regulation, we
expected to ﬁnd inappropriate expression of speciﬁc genes in
Figure 2. Gene Expression in HSC throughout Aging
The heat maps show expression levels for four different gene lists, with
the degree of overlap among the lists indicated on the right. Color
intensity indicates level of expression, where blue signifies low
expression and red signifies high expression. Each column delineates
the mean expression at 2, 6, 12, and 21 mo, and each row represents a
given gene within each gene list. ‘‘Expressed in HSCs’’ refers to genes
derived from a comparison of HSCs versus WBM.
doi:10.1371/journal.pbio.0050201.g002
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Epigenetic Dysregulation with Ageaged HSC. Indeed, with age, we observed a striking increase in
expression of the immunoglobulin (Ig) heavy chain gene (IgH;
;37-fold) and the immunoglobulin kappa (IgK) light chain
gene (;50-fold). Ig genes are not normally active in HSC, but
become highly expressed in B cells. We thus decided to
examine age-related transcription of the highly studied IgK
locus in more detail. The possibility that B cells were
contaminating the puriﬁed HSCs was excluded using anti-
bodies against two markers of early and mature B cells, CD19
and Il-7r (Figure S4A). In addition, a PCR-based assay to
detect Ig recombination [24] showed no evidence of V(D)J
recombination (Figure S4B).
Transcripts from an unrecombined IgK locus, termed
germline (GL) transcripts because they are removed during
V(D)J recombination, have been sighted previously in a pre–
pro-B cell line [25]; however, this occurs only after epigenetic
modiﬁcation, including DNA demethylation and subsequent
histone modiﬁcation [26]. Using reverse transcriptase PCR
(RT-PCR) to detect GL IgK transcripts in poly-A RNA
extracted from HSC from 2- and 24-mo-old mice, GL
transcripts were readily detectable in HSC from old mice,
but were absent in HSC from young mice (Figure 5D).
Sequencing conﬁrmed their GL structure, which included the
entire ﬁrst joining minigene (J1) and the constant region with
a poly-A tail. These data are consistent with a loss of
epigenetic regulation at the IgK locus with age in aged HSC.
Such epigenetic changes may enable access by NF-jB and
other factors that drive IgK gene expression, leading to
inappropriate expression in aged HSC.
Stem Cell Aging Is Uncoupled from Tissue and Organismal
Aging in p53 Mutant Mice
The tumor suppressor p53 is activated by stress and has
been implicated in the balance between longevity and tumor
formation [27]. Mutant mice expressing a truncated allele of
p53 (m allele) display an augmented p53 response, several
early-aging phenotypes, and hematopoietic defects, including
a blunted HSC proliferative response [28] and a lack of
sufﬁcient stem cell potential throughout life to maintain
longevity [29]. In contrast, mice with half the amount of p53
(p53
þ/ ) would be expected to live longer than wild-type (WT)
mice, except that they develop lethal tumors. Consistent with
the role of p53 in regulating cell proliferation, the p53
þ/ mice
exhibit increased stem cell proliferation [29].
We examined HSC from p53
þ/m and p53
þ/  HSC to gain
insight into the role of stem cells in organismal aging. HSC
from 12-mo-old p53
þ/m and p53
þ/  mice were isolated and
their gene expression proﬁles determined as above. These
two strains studied constitute the available extremes of p53
activity; the p53
þ/  mouse has half the p53 dose of WT mice,
and the p53
þ/m allele mice have more p53 activity than WT. A
pairwise comparison between the p53
þ/m and the p53
þ/  HSC
data (Tables S4 and S5) conﬁrmed up-regulation of the GO
categories DNA repair, Response to DNA damage stimulus,
and Apoptosis in the p53
þ/m HSC (Figure 6A, Tables S6 and
S7). Using the trend lines from the WT HSC time course, we
calculated for each gene a predicted age (in months) based on
the level of expression in both the p53
þ/m and p53
þ/  12-mo-
old mice. Interestingly, many of the genes from Table 1
Table 1. Selected Genes Differentially Expressed during HSC Aging
Symbol Gene Name Contrast Significance
Clu Clusterin 27.9 Stress response, senescence
App Amyloid beta precursor protein 23.7 Alzheimer disease, stress response
Selp Platelet-selectin 15.6 Inflammation, adhesion
Ctsb Cathepsin B 11.2 APP processing, Alzheimer
Dnaja2 DnaJ (Hsp40) homolog A2 7.8 Protein folding
Hspa8 Heat shock protein 8 7.4 Protein folding
Ctsc Cathepsin C 6.8 Proteolysis, inflammation
Icam1 Intercellular adhesion 1 5.6 Cell-cell adhesion, inflammation
Cox2 Cyclooxygenase 2 5.5 Inflammation
Ctss Cathepsin S 4.4 Proteolysis, inflammation
Cct6a Chaperonin subunit 6a (zeta) 4.2 Protein folding
Dnajb6 DnaJ (Hsp40) homolog B6 3.5 Protein folding
Tlr4 Toll-like receptor 4 3.5 Inflammation
Hspa8 Heat shock protein 8 7.8 Protein folding/stress
Hspa5 Heat shock protein 5 7.2 Protein folding/stress
Madh4 MAD homolog 4 (SMAD4)  3.6 TGF-b regulates HSC pool size
Xab2 XPA binding protein 2  5.5 DNA repair
Sirt3 Sirtuin 3  5.6 Chromatin silencing
Sirt7 Sirtuin 7  5.8 Chromatin silencing
Rad52 RAD52 homolog  6.8 DNA repair
Lmna Lamin A  8.4 Deficiency/mutation causes progeria
Spnb2 Spectrin beta 2  8.4 TGF-b regulates HSC pool size
Xrcc1 X-ray repair comp. defective repair in C. hamster cells 1  10.3 DNA repair
Eng Endoglin  11.2 TGF-b regulates HSC pool size
Blm Bloom syndrome homolog  12.1 DNA repair
Sirt2 Sirtuin 2  16.7 Chromatin silencing
The contrast value is calculated on the basis of fold-change and quality of fit (see Materials and Methods). A positive value indicates a gene that increases in expression throughout aging,
and a negative value one that decreases in expression.
doi:10.1371/journal.pbio.0050201.t001
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Epigenetic Dysregulation with Ageexhibit a ‘‘younger’’ expression pattern in the p53
þ/m mice,
including up-regulated genes such as Icam-1 ( 4.3 mo), CatnB
( 3 mo), and Dnaja2 ( 2.8 mo), as well as down-regulated
genes such as Madh4 ( 6.3 mo), Hdac6 ( 4.6 mo), Dnmt3b ( 5
mo), and Sirt7 ( 6.4 mo). Genes were then grouped on the
basis of GO, and the categories with a signiﬁcant shift in
predicted age (Wilcoxon t-test, p-value , 0.05) were identi-
ﬁed. Overall, the p53
þ/m mice appeared younger by 1–5 mo
compared to the p53
þ/ mice in the vast majority of signiﬁcant
GO categories (84/87) (Figure 6B and Table S8). Only three
categories were ‘‘older’’ in p53
þ/m mice, the most striking
being that of the inﬂammatory response, indicating that this
can be uncoupled from the other manifestations of aging.
Examples are P-selectin and Cox2, which are older in the
p53
þ/m compared to the p53
þ/  HSC by þ4.6 and þ6 mo,
respectively. The notion of relative youth of p53
þ/m stem cells
is supported by the observation that HSC from p53
þ/m mice do
not exhibit an age-related increase in number as is observed
in their WT counterparts [30], and have attenuated activity
after 5FU treatment [28], which can be explained by the lower
HSC proliferative capacity. This is also consistent with our
observation that HSC from the p53
þ/m mice form in vitro
colonies at a similar frequency as WT HSC, but with reduced
size, indicating a reduced proliferative capacity (Figure S5).
These results suggest that although p53
þ/m mice appear older
at a tissue and organismal level, the genetically imposed
Figure 3. Gene Ontology Analysis
(A) Fold enrichment over chance for selected GO categories of the Up-with-Age (red) and Down-with-Age (blue) gene lists. Bars without asterisks, p-
value   0.05. Triple asterisks (***) indicate p   0.005. The number of genes found within each gene list and found on the entire array are shown for
each GO category.
(B) GO-timer T
1/2-max for selected GO categories as a function of density over time. Areas of color correspond to the time at which a GO category is
undergoing the most rapid up-regulation (red) or down-regulation (blue). It is important to note that after a given GO category T
1/2-max, the expression
remains up-regulated (red) or down-regulated (blue).
doi:10.1371/journal.pbio.0050201.g003
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aging in HSC, causing them to remain relatively young at a
molecular level despite an inﬂammatory and aged tissue
milieu.
Discussion
Limitations in stem cell number or function have been
proposed to restrict longevity. However, we show here that in
WT mice, stem cells decline in function, when measured per
HSC, with a concomitant increase in their number, resulting
in a minimal net change in overall HSC activity, strongly
suggesting that stem cells are not likely to be a factor limiting
hematopoietic regeneration with age. However, their func-
tional deﬁcits do show that HSCs are impacted by the forces
of aging in a manner similar to that of differentiated cells
[31–34].
In our molecular analysis, we identiﬁed global age-related
changes in gene expression in murine HSCs, with a view to
identifying mechanisms that could be responsible for these
age-associated declines in HSC function. Genes involved in
inﬂammatory and stress responses dominated the group of
up-regulated genes, whereas those participating in chromatin
regulation and DNA repair were prominent among down-
regulated genes.
Many of the observed expression changes are corroborated
by a recent study of HSC aging [4]. Although the number of
genes that go up or down with age was similar between our
study and the one by Rossi et al. [4], the precise overlap
between the genes is modest: only 343 genes were differ-
entially expressed in both lists. We believe this is primarily
due to a different puriﬁcation strategy and array analysis that
was used in our study. Remarkably, however, the top ten
genes in both lists of genes that were Up-with-Age as well as
those that were Down-with-Age were identical, and the
magnitude of the changes was striking. For example, P-
selectin was found highly up-regulated with age, for a mean
fold-change of approximately 60 between the two studies.
Likewise, both studies observed the up-regulation of speciﬁc
protooncogenes, such as Runx1, that we believe could
contribute to the increased incidence of myeloid leukemia
with age.
In both studies, the inﬂammation markers P-selectin and
clusterin (both regulated by NF-jB) and protein-folding
genes such as Hspa8 and Dnajc3 were found up-regulated.
Additionally, we found genes involved in DNA repair and
chromatin maintenance (Xab2, Rad52, Polb, and Lmna) to be
down-regulated in both studies, supporting the notion that
HSC become epigenetically dysregulated.
The marked stress response exhibited by the HSC suggests
that a proinﬂammatory microenvironment exists within the
aging marrow. Studies of aging arteries, brain, and kidney
have also observed up-regulation of inﬂammatory markers
[33–35], but could not distinguish between immune cell
inﬁltration and intrinsic inﬂammatory response of the tissue.
The up-regulation of TLR4 (Toll-like receptor 4) (Table 1) is
especially intriguing because one of its principal signaling
targets is NF-jB, which regulates a variety of genes involved
Figure 4. Up-Regulation of P-selectin Cell Surface Expression and NF-jB Localization in Aged HSCs.
(A) An increasing percentage of HSCs express P-selectin (SelP) when examined by FACS, ranging from 3% (2-mo-old HSCs) to 81% (28-mo-old HSCs).
FITC, fluorescein isothiocyanate; PE, phycoerythrin.
(B and C) HSCs stained with anti-p65 NF-kB antibody (red) and DAPI (blue). Two-month-old HSCs contain approximately 3% nuclear-localized p65;
however, at 22 mo, approximately 71% show nuclear-localized p65.
doi:10.1371/journal.pbio.0050201.g004
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Epigenetic Dysregulation with AgeFigure 5. Density Plots of Coordinately Regulated Gene Expression for Chromosomes 4, 7, 10, and 13.
(A) The black line represents the local density of coordinate regulation for all unique microarray probes. A positive value (peak) indicates a region where
there are a greater number of up-regulated genes, whereas a negative value (valley) corresponds to a region of several down-regulated genes. The red
vertical line indicates a CORE that extends beyond the threshold of significance (blue and red lines; p , 0.05) estimated by 1,000 randomized test sets.
(B) Alignment of COREs on Chromosome 7 with previously published QTLs that represent chromosomal regions involved in age-related HSC function
and organismal lifespan. Only those COREs that localize within established QTLs are shown.
(C) Table showing the chromosomal alignment of COREs with known QTLs. QTLs are found on Chromosomes 2, 4, and 7 that contain COREs.
(D) RT-PCR for IgK GL transcripts and diagram of transcript alignment with the GL IgK locus. The star (*) in the first lane, for GL transcript1, indicates a
cDNA amplicon in young HSC that does not align with the IgK locus.
doi:10.1371/journal.pbio.0050201.g005
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Epigenetic Dysregulation with Agein the inﬂammatory response, including prostaglandin E2
synthase (Cox-2) and the adhesion molecules ICAM1 and P-
selectin [36] (Table 1). This molecular proﬁle resembles the
elevated inﬂammatory state previously described in older
mice (‘‘inﬂamm-aging’’ [37]); however, our mice were raised
in speciﬁc-pathogen–free conditions, and thus the inﬂamm-
aging can be independent of antigenic load. Strikingly,
Inﬂammatory Response was one of the few GO categories
found ‘‘older’’ in the p53
þ/m mice compared to the p53
þ/ 
mice. This correlates with the early-aging phenotype ob-
served at the organismal level in p53
þ/m mice, and suggests
that inﬂammation is an intrinsic effect of age.
The up-regulated inﬂammatory genes in aging HSCs may
have mechanistic implications for the decline of HSC
function. The ability of HSCs to engraft in bone marrow is
inﬂuenced by their homing properties; since cell adhesion
plays a critical role in the engraftment of HSCs, aberrant up-
regulation of genes encoding P-selectin and ICAM1 might
affect the ability of older HSCs to home to the bone marrow,
disrupting repopulation. Likewise, down-regulation of genes
in the TGFb signaling pathway such as SMAD4, endoglin, and
spectrin b2 (Table 1), may explain the increased number of
HSCs, because the TGFb pathway inﬂuences HSC pool size
[38].
Equally striking was the increased expression of clusterin
(clu) and amyloid beta precursor protein (App) in aged HSCs
(Table 1), because these proteins aggregate within plaques in
the brains of Alzheimer’s patients [39]. Cathepsin B, involved
in APP [40] processing, also increased in aged HSCs (Table 1).
Clusterin, containing chaperone homology, along with
several chaperonin subunits (beta, gamma, zeta, eta, and
theta) increased with age, as did stress-response genes Hsc70/
Hspa8, HSP90/Hspca, Bip/Hspa5, and several Hsp40 homologs
(Dnaja1, Dnaja2, Dnajb6, Dnajb10, and Dnajc3) (Tables 1 and S1).
These changes, as well as the approximately 6-fold enrich-
ment in NO-mediated signaling genes (Figure 3), may be in
response to oxidative stress, a common feature of aged cells
[41]. Some of these genes were previously noted to increase
with age in murine hearts and skeletal muscle, and to
decrease in animals on dietary restriction [31,32].
Figure 6. Gene Ontology for Pairwise Comparison and Age Differences between p53
þ/m and p53
þ/  HSC
(A) A pairwise comparison between the two genotypes reveals differences in p53-regulated pathways, including DNA repair, Response to DNA damage,
Apoptosis, and others. The number of genes found within each gene list and on the entire array are shown for each GO category.
(B) Using the best-fitting WT HSC aging data (R
2 , 0.50), age was extrapolated on a per-gene basis for both the p53
þ/m and p53
þ/  expression data.
Genes were clustered by GO categories, and categories with significant age differences between the two p53 mutants were identified (Wilcoxon t-test;
p-value , 0.05). Ninety-seven percent (84 of 87) of the GO categories were found to be younger (shifted left) in the p53
þ/m mice when compared to
p53
þ/  mice. Shown is a density plot of the difference between the two genotypes on a per-gene basis for each GO category, where red indicates the
highest density. Median differences in age for each GO category range from 1–5 mo and are demarcated by the white vertical line.
doi:10.1371/journal.pbio.0050201.g006
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Epigenetic Dysregulation with AgeAlthough inﬂammatory and stress-response genes in-
creased with age, genes that ensure transcriptional ﬁdelity
declined with age. For instance, lamin A declined with age and
is linked to normal human aging [42] and Hutchinson-Gilford
progeria [43] (Table 1). Likewise, Bloom syndrome homolog (Blm)
declined, mutations in which cause genomic instability,
hypermutability, and cancer predisposition [44]. Multiple
DNA repair genes, including Rad52, Xrcc1, and Xab2 were also
down-regulated. Because DNA damage is thought to be a
driving factor in aging [45], a blunted DNA damage response
could retard DNA repair, increasing the risk of retaining
mutations, leading to malignant transformation, one of the
hallmarks of old age.
It was surprising that HSCs from 12-mo-old early-aging
p53
þ/m mice appeared molecularly younger than age-matched
WT and p53
þ/  HSC. This suggests that a genetically imposed
lower rate of stem cell proliferation, as seen in the p53
þ/m
HSC, can reduce the apparent age of the HSC, despite their
residence in an environment that exhibits other outward
manifestations of aging [28]. But this reduced proliferative
capacity also results in poorer hematopoietic regeneration
activity, when the stem cells are examined at the population
level [28]. In other words, lower HSC proliferation results in a
more youthful stem cell, but poorer tissue regeneration, and
consequently an aged phenotype; this indicates that stem cell
proliferation and tissue regeneration are ﬁnely balanced to
maximize longevity, so that cell cycle disruption results in an
uncoupling of tissue and organismal aging from the aging of
the resident stem cell.
Finally, three lines of evidence in our work indicate broad
changes in epigenetic regulation with age. Several GO
categories (Figure 3A) and speciﬁc genes involved in tran-
scriptional silencing via chromatin regulation are down-
regulated with age, such as the SWI/SNF-related chromatin
remodeling genes (Smarca4 and Smarcb1), as well as three
histone deacetylases (Hdac1, -5, and -6) and a DNA
methyltransferase (Dnmt3b). Because these changes largely
occur mid-way through life (Figure 3B), they could easily be
envisioned to underlie inappropriate expression of addi-
tional genes. In addition, the CORE analysis revealed many
chromosomal regions coordinately changing with age, and
suggested an overall loss of transcriptional silencing. Finally,
inappropriate transcription from the IgK locus, known to be
driven by NF-jB activity following epigenetic modiﬁcation
enabling accessibility of the locus, was observed in old, but
not young, HSCs (Figure 5).
Together, these data suggest an epigenetic view of aging
that readily explains how so many diverse effects of age are
evident at molecular, cellular, and organismal levels, and
contrasts with the assumption that accumulation of lesions in
genomic DNA or mitochondria accounts for the major effects
of aging. Chromatin dysregulation could be a primary force
in aging; epigenetic changes in otherwise normal cells could
drive the loss of overall cellular functionality, as well as lay a
fertile ground for secondary genetic events that lead
irreversibly to oncogenic transformation. In this model,
inappropriate expression of protooncogenes, or down-
regulation of tumor suppressors, could result in a pre-
transformed state, similar to myelodysplastic syndrome, a
notion corroborated by another study of aging in murine
HSC [4] in which Runx1, Pml, and other protooncogenes were
up-regulated with age. Likewise, the increased transcriptional
accessibility of some loci may enable interactions between
otherwise distant chromatin domains, enhancing the like-
lihood of chromosomal translocations. Of particular note, the
IgK locus that we show is transcriptionally active in aged HSC,
is a well-established translocation partner with the Myc
protooncogene in the generation of hematopoietic malig-
nancies [46]. Moreover, IgK alleles have been shown to be
differentially located within the nucleus depending on their
state of activation [47], which could result in their juxtapo-
sition to oncogenes, increasing the likelihood of translocation
[48]. The role of epigenetic changes in cancer formation is
increasingly recognized [49]; here, we suggest that chromatin
dysregulation is a natural result of environmental insults with
age, and a primary driver of secondary effects of age,
including malignancy. A systems approach to the ways in
which inﬂammation, stress response, and epigenetic regu-
lation are linked may be essential to understanding aging and
cancer.
Materials and Methods
Mice and HSC puriﬁcation. All mice were housed in a speciﬁc-
pathogen–free barrier and fed autoclaved acidiﬁed water and mouse
chow ad libitum. C57Bl/6 CD45.1 mice were allowed to age to 2, 6, 12,
and 21–28 mo. HSCs were isolated as those cells that displayed the SP
phenotype of Hoechst 33342 efﬂux [50] and were SParKLS. Hoechst
and antibody staining was performed as previously described [11].
Sca-1 magnetic enrichment was performed with a Sca-1-biotin
antibody (eBioscience, http://www.ebioscience.com/) and antibiotin
microbeads (Miltenyi Biotec, http://www.miltenyibiotec.com/en/
default.aspx) on an AutoMACS (Miltenyi). The Sca-1–enriched cells
were suspended at a concentration of 10
8 cells/ml and incubated on
ice for 15 min with strepavidin-Alexa488 (Molecular Probes, http://
probes.invitrogen.com), c-Kit-phycoerythrin (PE; eBioscience), and
antibodies against the lineage markers: PE-Cy5 conjugated Mac-1, Gr-
1, CD4, CD8, B220, and Ter119 (eBioscience). Flow cytometric
analysis was performed on a triple-laser instrument (MoFlow;
Cytomation, http://www.dako.com). For cell cycle analysis, HSCs were
sorted into deionized water containing 0.1% sodium citrate and 50
lg/ml propidium iodide (PI) and analyzed with a FACScan ﬂow
cytometer (BD Biosciences, http://www.bdbiosciences.com).
Limiting dilution analysis. Forty CD45.2 mice were transplanted
with 3, 10, 30, 100, or 500 CD45.1 HSCs from either 2- or 21-mo-old
mice along with 1 3 10
5 CD45.2 WBM competitor cells. Engraftment
was measured by peripheral blood contribution 4, 8, and 16 wk post-
transplantation.
Immunoﬂuorescence studies. After sorting, the HSCs were
resuspended in 50% FCS in HBSS at a concentration of 25,000
cells/ml, and 0.2 ml of cell suspension was spun onto glass slides with a
cytocentrifuge (Wescor, http://www.wescor.com) at 800 rpm for 4 min.
Fixed slides were blocked for 1 h with 30% goat serum in PBS, stained
for 1 h with polyclonal anti-p65 antibody (1:100 in PBS; eBioscience),
and stained with secondary antibody (1:250 and DAPI 1:1,000). Texas
Red background immunoﬂuorescence was established with controls
containing no primary antibody at an exposure time longer than 5 s.
Texas red immunoﬂuorescence images were photographed for 0.8 s.
RNA puriﬁcation and hybridization to microarrays. Total RNA was
isolated from 2.5–5 3 104 HSCs (2–5 mice pooled per microarray)
with an RNAqeuous kit (Ambion, http://www.ambion.com), treated
with DNAseI, and precipitated with phenol:chloroform. This RNA
was linearly ampliﬁed in two rounds of T7-based in vitro tran-
scription (MessageAmp kit; Ambion), and labeled in the last round
with biotin-conjugated UTP and CTP (Enzo Biochem, http://www.
enzo.com). Ampliﬁed biotinylated RNA (20 lg) was diluted in
fragmentation buffer (5X; 200 mM Tris-acetate [pH 8.1], 500 mM
KOAc, and 150 mM MgOAc in DEPC water) to a ﬁnal volume of 40 ll,
incubated at 94 8C for 25 min, and stored at 80 8C. A sample was run
on a 4% nondenaturing agarose gel to conﬁrm an RNA fragment
length of approximately 50 base pairs. The labeled RNA was
hybridized to MOE430A chips according to standard protocols
(Affymetrix, http://www.affymetrix.com); the chips were then washed
and counterstained with PE-conjugated streptavidin and a biotiny-
lated anti-streptavidin antibody. The raw image and intensity ﬁles
were generated with MAS 5.0 software (Affymetrix). All microarrays
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Epigenetic Dysregulation with Agepassed several quality controls as previously described [14]. Normal-
ization and model-based expression measurements were performed
with GC-RMA [51] (http://www.bioconductor.org).
Linear regression and contrast analyses. To identify genes whose
expression varied signiﬁcantly over time, we ﬁt smooth curves to gene
expression proﬁles by regression analysis. A quadratic polynomial
was ﬁt to the proﬁle of each gene by use of LIMMA [52], enabling us
to analyze progressive changes as well as peaks and valleys in
expression over time. The Up-with-Age and Down-with-Age gene lists
were identiﬁed by applying a linear contrast model and modiﬁed t-
statistics from an empirical Bayes procedure [52] coupled with a
linear step-up [53] multiple-testing correction (to estimate and
minimize the false discovery rate to less than 5%) and a fold-change
criterion of at least 2-fold for the 19-mo study period. In short, this
contrast model is a composite score of reproducibility (t-statistic, p-
value   0.05) and fold-change (.2-fold), which simply conveys a
degree of difference (contrast) in gene expression over time.
Gene Ontology analyses. To investigate the biological signiﬁcance
o ft h eg e n el i s t sd e s c r i b e da b o v e ,w eu s e dG O( h t t p : / / w w w .
geneontology.org). GO is a controlled vocabulary that describes gene
biological roles and is arranged in a quasi-hierarchical structure from
more general terms to the more speciﬁc. After mapping each gene in
the two lists to the GO tree structure, we determined the number of
genes at or below any given node in the GO hierarchy and the
amount of statistically signiﬁcant enrichment (Fisher exact p-value)
for each GO node relative to chance observation, using a previously
developed procedure [54]. To assess the emergence and disappear-
ance of enriched GO categories, we deﬁned the time of half-maximal
expression change (T
1/2-max) for each gene in each category over the
time interval. For genes whose maximal expression values were
outside the 2- to 21-mo interval, the T
1/2-max was determined as the
intermediate expression value between the expression at 2 and 21
mo. For genes whose extreme expression values were within the
interval, the T
1/2-max was determined as the intermediate expression
value between the expression at 2 mo and that extrema. Genes were
grouped by GO category, yielding reliable estimates of time of
induction and reduction for a given biological process. We conducted
this analysis separately for the Up-with-Age and Down-with-Age gene
lists.
CORE analysis method. To identify COREs, we obtained the
genome coordinates of the Affymetrix MOE430A array from the
MM5 build of the UCSC Genome Browser. To compare the
locations of age-induced or age-repressed genes, we divided all
genes into two disjoint classes based on the sign of the 21-mo versus
2-mo contrast. Redundant probe sets were removed by grouping all
probe sets by Entrez Gene annotation. Because not all probe sets
for a single Entrez Gene identiﬁer have the same sign for the
contrast score, the sign of the mean value was assigned to the Entrez
Gene identiﬁer. To compare the positions of these locations, we
constructed a Gaussian kernel density estimate by chromosomal
position for genes that increased with age and genes that decreased
with age. We then calculated a ratio of these density estimates for
the two groups. This ratio represents the density of genes that
increase (peak) or decrease (valley) with age. A permutation test was
performed to estimate the p-value where gene locations were
randomly swapped along each chromosome, maintaining gene
density but randomizing direction of regulation (up/down), Density
estimate ratios were calculated based on 1,000 random permuta-
tions. This calculation enabled us to estimate a threshold of
statistical signiﬁcance such that peaks and valleys (high densities
of age-induced and age-repressed genes) exceeding the 0.025 and
0.975 permutation-based quantiles were judged to be statistically
signiﬁcant at an estimated p-value of 0.05.
Immunoglobulin assays. Puriﬁed cells were sorted into lysis/PCR
buffer, and PCR was performed as previously reported [24]. For GL
RT-PCR, approximately 20,000 HSCs from either young or old mice
were sorted into HBSS, and RNA was isolated by the RNAqueous kit
(Ambion). RT-PCR was performed with an oligo-dT primer and
SuperScript II (Invitrogen, http://www.invitrogen.com) followed by 50
cycles of PCR. RT-PCR fragments were puriﬁed, cloned into the Topo
2.1 vector (Invitrogen), and sequenced. IgH recombination primers
are previously published [24]. IgK GL transcript primers include 59-
CTTCAGTGAGGAGGGTTTTTG-39 (forward 1), 59-ACTAT-
GAAAATCAGCAGTTCTC-39 (forward 2), and 59-CGTTCA-
TACTCGTCCTTGGTC-39 (reverse).
p53 Gene Ontology analysis. To assess the age-related expression
differences between the p53
þ/m and p53
þ/ mice, genes with best-ﬁtting
trend lines (R
2 . 0.50) from the WT HSC aging time course were
selected, and a predicted age (in months) was extrapolated for each
gene based on the level of expression for both the p53
þ/m and p53
þ/ 
12-mo-old mice. Genes were grouped on the basis of GO for both
phenotypes and the categories with a signiﬁcant shift in age
(Wilcoxon t-test) between the p53
þ/m and p53
þ/  mice were identiﬁed
by a p-value   0.05 and a median aged difference of greater than 1
mo. Mice used in these experiments have been back-crossed onto the
C57Bl/6 background for four or more generations.
Datasets All data can be downloaded from our Web site http://rd.
plos.org/pbio.0050201. In addition, all microarray data ﬁles have been
deposited in the Gene Expression Omnibus (accession number
GSE6503).
Supporting Information
Figure S1. Fluorescence Activated Cell Sorter Analysis of SP Cell
Lineage Expression
Young (2 Mo) and Old (21 Mo) SP cells express very low levels of
differentiated cell surface lineage markers (Gr-1, Mac-1, B220,
Ter119, CD4, and CD8).
Found at doi:10.1371/journal.pbio.0050201.sg001 (492 KB PDF).
Figure S2. Fluorescence Activated Cell Sorter Analysis of Peripheral
Blood Contribution of HSC from 21-Mo-Old Mice after Transplant
HSC from old mice reconstitute all three lineages of the peripheral
blood including myeloid (Gr-1 and Mac-1), B cell (B220), and T cell
(CD4,8) at both 4 and 16 wks post-transplant.
Found at doi:10.1371/journal.pbio.0050201.sg002 (704 KB PDF).
Figure S3. Real-Time PCR of selected Up-Regulated HSC Aging
Genes
Error bars represent standard error from two separate experiments.
mRNA was puriﬁed from HSC sorted independently from the HSC
used in the microarray studies.
Found at doi:10.1371/journal.pbio.0050201.sg003 (441 KB PDF).
Figure S4. CD19 and IL-7r Are Not Expressed on HSC and PCR-Based
IgH Recombination Assay
(A) Young (red line) and old (green line) HSC do not express CD19 or
IL7r compared to WBM (black line) on the basis of ﬂuorescence
activated cell sorting (FACS).
(B) The presence of DNA by a-actin (‘‘A’’), IgH GL locus (‘‘Ig’’), and
recombined locus (‘‘R’’) have been examined using PCR in several
populations including spleenocytes, B cells (B220
þ Mac-1
 ), myeloid
cells (Mac-1
þ B220
 ), 2-mo-old HSC, 21-mo-old HSC, and 21-mo-old
myeloid cells. No recombination was detected in any HSC.
Found at doi:10.1371/journal.pbio.0050201.sg004 (2.3 MB PDF).
Figure S5. Single HSC Methylcellulose Assays
Single HSC from WT, p53
þ/ , and p53
þ/m 12-mo-old mice were sorted
into 96-well plates containing methylcellulose (M3434; Stem Cell
Technologies, http://www.stemcell.com) and allowed to form colonies
for 14 d. p53
þ/m HSC were found to give rise to signiﬁcantly smaller
colonies (a single asterisk [*] indicates p-value   0.004) when ten
colonies were pooled and the average number of cells per colony was
determined for 60 colonies (n ¼ 6) for each genotype. All three
genotypes formed colonies at approximately the same frequency as
shown in the table based on the percent of wells containing a colony
(96-well plate).
Found at doi:10.1371/journal.pbio.0050201.sg005 (484 KB PDF).
Table S1. Up-with-Age in HSC Gene List
Found at doi:10.1371/journal.pbio.0050201.st001 (311 KB XLS).
Table S2. Down-with-Age in HSC Gene List
Found at doi:10.1371/journal.pbio.0050201.st002 (292 KB XLS).
Table S3. Table for COREs
Found at doi:10.1371/journal.pbio.0050201.st003 (245 KB XLS).
Table S4. Genes Up in p53
þ/m Compared to p53
þ/  HSC
Found at doi:10.1371/journal.pbio.0050201.st004 (125 KB XLS).
Table S5. Genes Up in p53
þ/  Compared to p53
þ/m HSC
Found at doi:10.1371/journal.pbio.0050201.st005 (105 KB XLS).
Table S6. Gene Ontology Enrichment Results for Up in p53
þ/m HSC
Found at doi:10.1371/journal.pbio.0050201.st006 (58 KB XLS).
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Epigenetic Dysregulation with AgeTable S7 Gene Ontology Enrichment Results for Up in p53
þ/  HSC
Found at doi:10.1371/journal.pbio.0050201.st007 (77 KB XLS).
Table S8. Gene Ontology Table of Age Differences between p53
þ/ 
and p53
þ/m HSC
Found at doi:10.1371/journal.pbio.0050201.st008 (24 KB XLS).
Accession Numbers
Entrez Gene (http://www.ncbi.nlm.nih.gov/sites/entrez?db¼gene) ID
accession numbers for the genes discussed in this paper are App
(11820), Blm (12144), CatnB (12387), Cct6a (12466), CD150 (6504), CD19
(12478), CD45 (19264), CD48 (12506), c-Kit (16590), Clu (12759), Cox2
(19225), Ctsb (13030), Ctsc (13032), Ctss (13040), Dnaja1 (15502), Dnaja2
(56445), Dnaja2 (56445), Dnajb10 (56812), Dnajb6 (23950), Dnajc3
(19107), Dnmt3b (13436), Dnmt3b (13436), Eng (13805), Hdac1
(433759), Hdac5 (15184), Hdac6 (15185), Hdac6 (15185), Hspa5
(14828), Hspa8 (15481), Hspca (15519), Icam1 (15894), IgH (111507),
IgK (243469), Il-7r (16197), Lmna (16905), Madh4 (17128), p53 (22059),
p65 (19697), Pml (18854), Rad52 (19365), Runx1 (12394), Sca-1 (110454),
Selp (25651), Sirt2 (64383), Sirt3 (64384), Sirt7 (209011), Smarca4
(20586), Smarcb1 (20587), Spnb2 (20742), Tlr4 (21898), Xab2 (67439),
and Xrcc1 (22594).
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